Develop next-generation human nervous-system microphysiological systems (R21, no clinical trials)
This NIH R21 NOFO funds technology-focused projects to build advanced human cell–derived microphysiological systems (MPS)—including organoids, tissue-chips, or xenografts—that better reproduce circuit-level structure, maturation, connectivity and long-term function of brain, spinal cord, or sensory organs. Applications should prioritize improving assay fidelity, reproducibility, multi-lineage …
Human cell-based assays (e.g., using induced pluripotent stem cells) hold promise for identifying molecular, cellular and circuit defects, identifying novel targets and developing new therapeutics for patients with complex brain and other nervous system disorders. However, the methods to generat…
Funding Source
Awards & funding
Eligibility
Foreign entities: Non-domestic (non-U.S.) entities (foreign organizations) are eligible to apply. Non-domestic components of U.S. organizations are eligible. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Required registrations (must be completed/active be…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers